GSKGSK
13F holders, Q2 2024 (June 30)7holders −2
0new positions
1sold out
$38.50avg. 13F price*
At the end of Q2 2024, 7 institutions reported holding GSK PLC (GSK) in their 13F filings, down 2 from Q1 2024. 0 opened new positions and 1 sold out. The largest holders were Kahn Brothers Group Inc. ($47.8M), Eagle Asset Management Inc. ($642K) and Columbia Asset Management ($351K).
- Company
- GSK PLC
- Filed as
- GLAXOSMITHKLINE PLC (Q2 2024)
- CUSIP
- 37733W105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $40K |
All 13F filers, Q1 2024 → Q2 2024: 1,140 shares bought and 13,303 shares sold, net −12,163 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Kahn Brothers Group Inc. | 8.03% | Reduce -1.0% | 1,241,261 | $47.8M |
| Eagle Asset Management Inc. | 0.00% | Add +1.6% | 16,722 | $642K |
| Columbia Asset Management | 0.07% | Add +9.5% | 9,125 | $351K |
| Paradigm Asset Management Co. LLC | 0.02% | No change | 1,800 | $69K |
| PARK CIRCLE Co | 0.03% | No change | 800 | $31K |
| Byrne Asset Management LLC | 0.00% | Add +160.7% | 146 | $6K |
| Huntington National Bank | 0.00% | No change | 1 | $40 |
"% of holder's portfolio" is GSK's weight in each manager's 13F, not the share of GSK PLC the manager owns.